Identification of kinase modulators as host-directed therapeutics against intracellular methicillin-resistant Staphylococcus aureus
Frontiers in Cellular and Infection Microbiology · 25.03.2024 · 14
DOI: 10.3389/fcimb.2024.1367938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 25.03.2024. Verfasst von Robin H G A van den Biggelaar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
The increasing prevalence of antimicrobial-resistant Staphylococcus aureus strains, especially methicillin-resistant S. aureus (MRSA), poses a threat to successful antibiotic treatment. Unsuccessful attempts to develop a vaccine and rising resistance to last-resort antibiotics urge the need for alternative treatments. Host-directed therapy (HDT) targeting critical intracellular stages of S. aureus emerges as a promising alternative, potentially acting synergistically with antibiotics and reducing the risk of de novo drug resistance. We assessed 201 ATP-competitive kinase inhibitors from Published Kinase Inhibitor Sets (PKIS1 and PKIS2) against intracellular MRSA. Seventeen hit compounds were identified, of which the two most effective and well-tolerated hit compounds (i.e., GW633459A and GW296115X) were selected for further analysis. The compounds did not affect planktonic bacterial cultures, while they were active in a range of human cell lines of cervical, skin, lung, breast and monocyte origin, confirming their host-directed mechanisms. GW633459A, structurally related to lapatinib, exhibited an HDT effect on intracellular MRSA independently of its known human epidermal growth factor receptor (EGFR)/(HER) kinase family targets. GW296115X activated adenosine monophosphate-activated protein kinase (AMPK), thereby enhancing bacterial degradation via autophagy. Finally, GW296115X not only reduced MRSA growth in human cells but also improved the survival rates of MRSA-infected zebrafish embryos, highlighting its potential as HDT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
- Institute of Biology Leiden, Leiden University, Leiden, Netherlands.
- Global Health Medicines R&D, GlaxoSmithKline, Tres Cantos, Spain.
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
van den Biggelaar, R. H. G. A., Walburg, K. V., van den Eeden, S. J. F., van Doorn, C. L. R., Meiler, E., de Ries, A. S., Meijer, A. H., Ottenhoff, T. H. M., & Saris, A. (2024). Identification of kinase modulators as host-directed therapeutics against intracellular methicillin-resistant Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1367938
Vancouver
van den Biggelaar RHGA, Walburg KV, van den Eeden SJF, van Doorn CLR, Meiler E, de Ries AS, et al. Identification of kinase modulators as host-directed therapeutics against intracellular methicillin-resistant Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1367938
BibTeX
@article{vandenBiggelaar2024,
author = {van den Biggelaar, Robin H G A and Walburg, Kimberley V and van den Eeden, Susan J F and van Doorn, Cassandra L R and Meiler, Eugenia and de Ries, Alex S and Meijer, Annemarie H and Ottenhoff, Tom H M and Saris, Anno},
title = {Identification of kinase modulators as host-directed therapeutics against intracellular methicillin-resistant Staphylococcus aureus},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
volume = {14},
doi = {10.3389/fcimb.2024.1367938}
}
EUVIMED